Company Filing History:
Years Active: 2011
Title: Marija Ribic: Innovator in Anti-Inflammatory Macrolides
Introduction
Marija Ribic is a notable inventor based in Durmanec, Croatia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel macrolides with anti-inflammatory properties. Her work is essential in addressing various inflammatory diseases and conditions.
Latest Patents
Marija Ribic holds a patent for "Macrolides with anti-inflammatory activity." This invention relates to novel semi-synthetic macrolides that exhibit anti-inflammatory activity. Specifically, it focuses on 14- and 15-membered macrolides substituted at the 4″ position, along with their pharmaceutically acceptable derivatives. The patent also covers processes and intermediates for their preparation, pharmaceutical compositions containing them, and their application in treating inflammatory diseases associated with excessive secretion of TNF-α, IL-1, IL-8, IL-2, or IL-5, as well as inhibiting excessive lymphocyte proliferation and granulocyte degranulation. Marija has 1 patent to her name.
Career Highlights
Marija Ribic is currently associated with Glaxo Group Limited, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and treatment of inflammatory conditions, making her a valuable asset in the pharmaceutical industry.
Collaborations
Marija has collaborated with notable colleagues, including Sulejman Alihodzic and Martina Bosnar, who contribute to her research endeavors and the development of innovative solutions in the field.
Conclusion
Marija Ribic's contributions to the field of anti-inflammatory macrolides highlight her innovative spirit and dedication to improving healthcare. Her patent and ongoing work at Glaxo Group Limited underscore her role as a key figure in pharmaceutical advancements.